Lara Sullivan, M.D. 13D/13G Filings for

Lara Sullivan, M.D. 13D and 13G filings for :

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2021-10-21
6:52 pm
Purchase		2021-10-1313DPyxis Oncology, Inc.
PYXS		Lara Sullivan, M.D.2,313,364
6.660%		2,313,364increase
(New Position)		Filing